- Home
- RTO vs PEN Comparison
RTO vs PEN Comparison
Compare RTO & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RTO
- PEN
- Stock Information
- Founded
- RTO 1925
- PEN 2004
- Country
- RTO United Kingdom
- PEN United States
- Employees
- RTO N/A
- PEN N/A
- Industry
- RTO Business Services
- PEN Medical/Dental Instruments
- Sector
- RTO Consumer Discretionary
- PEN Health Care
- Exchange
- RTO Nasdaq
- PEN Nasdaq
- Market Cap
- RTO 12.0B
- PEN 10.6B
- IPO Year
- RTO N/A
- PEN 2015
- Fundamental
- Price
- RTO $24.98
- PEN $263.05
- Analyst Decision
- RTO Hold
- PEN Strong Buy
- Analyst Count
- RTO 1
- PEN 16
- Target Price
- RTO N/A
- PEN $302.93
- AVG Volume (30 Days)
- RTO 740.0K
- PEN 463.3K
- Earning Date
- RTO 07-31-2025
- PEN 10-29-2025
- Dividend Yield
- RTO 2.27%
- PEN N/A
- EPS Growth
- RTO N/A
- PEN 916.05
- EPS
- RTO 0.13
- PEN 3.74
- Revenue
- RTO $7,581,860,530.00
- PEN $1,280,152,000.00
- Revenue This Year
- RTO $13.39
- PEN $15.52
- Revenue Next Year
- RTO $2.81
- PEN $14.20
- P/E Ratio
- RTO $37.32
- PEN $70.20
- Revenue Growth
- RTO N/A
- PEN 12.92
- 52 Week Low
- RTO $19.60
- PEN $184.80
- 52 Week High
- RTO $27.37
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- RTO 51.51
- PEN 48.02
- Support Level
- RTO $25.30
- PEN $270.54
- Resistance Level
- RTO $25.97
- PEN $280.14
- Average True Range (ATR)
- RTO 0.41
- PEN 7.65
- MACD
- RTO 0.01
- PEN -1.97
- Stochastic Oscillator
- RTO 59.09
- PEN 10.95
About RTO Rentokil Initial plc
Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in 89 countries. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.